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CHAPTER 1";.; ~., ;J. d '. t~
1.1 PORPHYRINS
1.1.1 WHAT ARE PORPHYRINS I I ~ I
Porphyrins are nitrogen-containing.compounds derived from the parent molecule
tetrapyrrol,eporphin. Both natural and synthetic porphyrins exist. Some natural
porphyrins are found in hemoglobin, myoglobin, cytochromes, and chlorophyll.
Porphyrins are classified on the basis of the nature ofthe side chains replacing the
hydrogens at positions 1-8 (Figure 1.1); methyl, ethyl, vinyl, and propionic acid are .
common substituents.
Formation of porphyrin-metal complexes results in altered porphyrin absorbance
spectra. The spectral characteristics are dependent on both the metal involved and the
solvent which is being used. This dependence on metal type is specific enough to allow
differentiation between metals in a given solvent. The absorbance spectrum and the
extinction coefficient of porphyrins and metalloporphyrins are known to be affected by
the solvent. Solvent induced spectral changes result from the interactions effecting the
pi-electron orbitals of the porphyrin. The same factors are involved in the spectral
changes observed upon side chain substitution. Increases in pi-electrons cause red shifts
ofthe absorbance and fluorescence bands while decreases in pi-electrons cause blue
shifts (shorter wavelengths) of the absorbance and fluorescence bands (1).
Interaction with individual organic molecules strongly affects the spectral
characteristics of porphyrins, as well (2-4). Amino acids (5, 6) and small peptides (7, 8)
alter the absorbance spectra of porphyrins, each molecule resulting in unique spectral
I
characteristics (3). Porphyrin-protein int1eraetions affect the spectrateharacteristics, as'
well, as shown in the interaction with serum albumin (9-1J~ and other proteins (12). II.'
Porphyrins are known enzyme inhibitors that have been shown'to inhibit AChE
(13, 14). They have been studied in this capacity as photoactivated insecticides (15), and
for use in treating Alzheimer's disease andlmyasthenia gravis (16, 17). Porphyrins have
also been shown to inhibit telomerase and Hepatitis C virus serine protease (18).
Metalloporphyrins· hav,e been shown to be potent inhibitors ofhuman immunodeficiency
viAlS (lllV) type ,1 and 2 reverse transcriptases (19). Porphyrins have also been shown to
bind· to DNA (20, 21), and are used in ]1hotodynamic therapy (22).
1.1.2 PORPHYlUNS AS, SENSORS ' II
The spectrophotometri,ccharacteristics of porphyrins allow for their application in
a wide variety ofsituations as colorimetric indicators. A large volume of literature
reflects the interest in porphyrins for use in molecular recognition. Porphyrins have been
used for detection of sugars, alcohols, amino acids, amines, DNA, and Quinones in
solution. The uniqueness of the interactions, providing specific spectrophotometric
markers in the UV/vis and fluorescence spectra for different compounds, allows for wide
application ofporphyrins in this field. In the case ofamino acids, interaction specificity
allows for determination ofchirality based on the peak positions resulting from the
interaction (23). Reflectivity measurements have been similarly used. A surface coated
with gold has been used as a foundation for a film ofporphyrins. The spectrum of
reflected light or the intensity ofaparticular, wavelength is then affected by exposure to
interactive compounds (24. 25).
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Porphyrinic senS"ors for detection ofeleetroaetiveanalytes <Can a1s"o maKe use, of ;
the formation ,of.thin films:of metalloporphyrins, on the surface 'oran eleetr:Gde~ .In ~ifl
way it is possible to detect the oxidation or reduction of'the analyte-basedon the current
generated. Specificity arises from the possibility of modifying the side chain constituents
and the incorporated metal of the porphytin, therefore altering its redox properties. This
type ofsensor is used for detection of metal cations and nitric oxide{16. 27).
Anion~selective potentiometric sensors can be based on the doping -ofnon- .
conductive membranes with metalloporphyrins. This incorporation requires interaction
ofthe anion as a ligand. The ability ofthe anion to interact with the porphyrin is
therefore restricted by the metal irico'rporated and the side chains involved. This type of
sensor can be used for detection ofcompounds such as salicylate, nitrite, .and 2-
hydroxybenzyhydroxamate (a therapeutic agent) as well as nickel (27-29).
1.2 ACETYLCHOLINESTERASE
1.2.1 STRUCTURE AND FUNCTION
Acetylcholinesterase (AChE) is a 537 amino acid residue protein containing 12
strand J3-sheets and 14 a.-helices. The x-ray crystallographic structure has been
determined to 2.8 Aresolution (30). The primary biological role of AChE is the
tennination ofimpulse transmission at the cholinergic synapses. This is accomplished by
hydrolyzing the neurotransmitter acetylcholine (ACh) to acetate and choline.
The active site ofAChE lies in a deep narrow gorge, which penetrates nearly to
the center of the protein. The active site is composed oftwo subsites. The esteratic site
resembles that of the other serine hydrolases and requires major participation ofthe Se~(lO
3
residue..Also involved in binding ACh, are Trp84, Gly1l8, Gly1l9, and Ala~OI.1 The ACh is
guided into the active site by the many aromatic residues, which tine the active site gorge.
Inhibitors ofAChE are those compounds which block the hydrolysis of the
substrate acetylcholine, resulting in slower catalytic rates and th.erefore larger Micha.elis
constants (Km). Inhibitors may bind in th.e active site or at a peripheral site. Those;
chemicals, which bind at the active site, are called competitive inhibitors. They do not
effect the maximal catalytic rate, Vmax. Chemicals binding to the peripheral sites and
resulting in larger K m values are mixed inhibitors. These inhibitors will cause a change
in the Vmax value.
The importance ofAChE -is its -basis as a target for attack. The inhibition of
AChE is used as a method of pest control and .as a weapon. Because organophosphate
compounds, which are the major constituents ofmany insecticides and nerve agents,
covalently bind to the serine residue, they semi-permanently or permanently, depending
on the compound, block the hydrolysis,ofACh. When this happens, the nerve impulse
receptors constantly receive signals. In humans, this overstimulation causes salivation,
sweating, loss ofmuscle control, spasm, and death. Death is normally the result of
respiratory failure (3.2). More recently, reversible inhibition of AChE has been tested as a
method oftreating diseases such as A1zh,eimer's (16).
1.2.2 USE AS A SENSOR
Since the catalytic activity ofa given amount of AChE is reduced upon exposure
to an.organophosphate" a measurement in the "change in activity can be used to detect the
probable presence of one of these chemicals. There are several sensors based on this
idea.
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Bac.hmann and co-workers describe a method ofmonitoringimmobHized AChE
activity by electrochemicaUy monitoring oxidation ofthiocholine produced upon . • '1
hydrolysis ofATe. A baseline ofAChE activity must' first be collected before a sample
can be exposed to inhibitors. After incubation with the preferred inhibitor" the AChE
activity is again measured. The before and after activity are compared to determine the
level of inhibition of the enzyme and therefore the concentration of the inhibitor. This
method is also used for detection of cholinesterase-inhibiting insecticides (33).
This is not a unique method ofdetection for enzyme inhibitors. It is employed
repeatedly using different techniques for monitoring activity ofAChE, but in all cases a
baseline ofcatalytic activity is required. This method is not limited. to application with
AChE. It is also used with other enzymes) such as choline oxidase.
butyrykholinesterase. organophosphorus hydrolase (33-59). It would be better if a
method ofdetermination could be developed which did not require a baseline ofenzyme
activity. Enzyme stability increases upon immobilization) however, activity will decrease
as the enzyme ages. In addition. sensitivity may be limited by the method of
detennination of enzymatic activity. A low concentration of inhibitor may not be
sufficient to alter the enzymatic rate noticeably. These factors discourage the use of a
sensor ofthis type other than in a lab environment.
The need for a detector ofchemical warfare agents for use by first-responders and
military personnel is intense and ongoing. An ideal sensor would be one that is agent-
specific with a minimum ofinterferents and false positive readings and that is compact,
battery-powered. has a long shelf life, is sensitive, and reports in real-time. Devices with
as many ofthese characteristics as possible are 8tiB sought.
5
j
Current sensors ornerve agents that inhibit acetylcholinesterase are based
primarily upon comparison ofcatalytic rates ofacetyJcholine esterase at a giv,en time to a
baseline, background, or pre-exposure level (34-58, 60, 61). The measurement of
catalytic rates may involve multiple st,eps involving the addition or changing of one or
more reagent solutions, a somewhat undesirable operating characteristic.
Sensors can be broadly classified into two groups: detectors of specific agents
(e.g., VX) (6, 40-42, 49, 62) and detectors ofAChE inhibitors in general (12, 34, 38, 45,
46, 48, 51, 53-55, 57,58). There is a need for both types of sensor. The central core
technology of any sensor/detector is a system that it transduces the presence of the











FIGURE 1.1 The structure of the parent molecule, tetrapyrroleporphin, from which
porphyrins are derived. Hydrogens at positions 1-8 are replaced by the
side chains for the porphyrins.
7
CHAPTER 2
2.1 THE RESEACH IDEA
Porphyrin interactions with proteins have been widely studied and are being
applied in many ways, as mentioned in Chapter 1. Ofespecial interest are the changes in
the spectrum ofporphyrins upon binding to an enzyme and the fact that some porphyrins
have been shown to be competitive inhibitors (14). Due to the reactivity of the
porphyrins, it may be possible to cause a change in the spectrum ofthe porphyrin-enzyme
complex by introducing other chemicals to the environment. Chemicals which bind the
active site ofan enzyme may effect the complex formed by an enzyme and a porphyrin
which is a competitive inhibitor of that enzyme. Because ofthe biological significance of
acetylcholinesterase, interactions between it and porphyrins were investigated.
AChE has been used as a sensor by measuring the activity ofthe AChE remaining
uninhibited after introduction ofan inhibitor to the environment. This indicates the
percentage ofthe AChE which has presumably been affected. This approach requires a
baseline of AChE activity for comparison and allows for introduction of error due to
enzyme instability. The preferable approach would be to measure the AChE which had
been affected by the inhibitor directly. Ifa porphyrin-enzyme complex could be formed
with spectral characteristics which are sensitive to inhibitors ofAChE, a colorimetric
sensor could be based on those changes.
In the pursuit of this idea, porphyrins were tested for their ability to inhibit, and
therefore bind, AChE. Such a porphyrin was then investigated for the type of interaction
it displayed with AChE. Questions addressed were the following:
1. Do the porphyrin and enzyme interact?
8
2. Does this interaction yield a spectral signature?
3>WhaUs the nature'ofthe interaction? \1 : .. ,II (:
4.. What, ifany, are the effects on the spectral signature upon addition ofsubstrate to the
environment? ; , , . .iol
5. What) if any, are the effects on the spectral signature upon addition ofother known
AChE inhibitors?' j _
6. What are the limits of sensitivity for the changes caused by competitive inhibitors?
2.2 MATERIALS AND METHODS
Acetylcholinesterase (AChE, type V-S from electric eels), tetracaine, procaine
HCl, acetylcholine iodide (AChI), dithiobisnitrobenzoic acid (DTNB) and
acetylthiocholine iodide (ATC) were obtained from Sigma (St. Louis, MO) and used
without further purification. Monosulfonate tetraphenyl porphine (TPPSl, Figure 2.1) was
obtained from Frontier Scientific (Logan, UT).
Enzyme assays were'co~ducted in 3 mL of 100 roM pH 8 phosphate buffer
maintained at 25C according to the method of EUman (63) with slight modifications: (l)
reaction rates were measured using a Gilford single beam spectrophotometer and (2)
AChE was dissolved in 100 roM pH 7 phosphate buffer instead of gelatin and water. In
order to avoid possible contributions from the absorption of TPPS1 (ft.max = 405 nm),
reaction rates were measured at 435 nm instead of412 nm. The absorbance ofthe yellow
anion of5-thio-2-nitro-benzoie acid, the result ofthe DTNB-thiof reaction, at 435 om is
76% ofthat at 412 nIn.
Absorbance spectra ofTPPS l and TPPSI in the presence ofAChE, tetracaine,
procaine
1
and AChI were recorded in 5 mM pH 8 sodium phosphate (Sorenson) buffer
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with a Cary 4E spectrophotometer at 0.02 am resolWion:. Difference spectra WeFe r-
obtained by subtraction ofabsolute spectra using Gramsli2,(GUactie Industries; Sal~
NH).
Fluorescence spectra ofTPPS1 in the presence/absence ofAChE were reoordedin
5 mM pHS sodium phosphate (Sorenson) buffer. Fluorescence spectra were collected
with a Spex FJurO'max: 3 spectrofluorometer using 2.S nm-resoJution far excitation
wavelen;gth and 1.0 nm resolution~for emission wavelength, Final reagent concentrations
arc-given in the fi.gure captions. Spectral analysis 'Was again preformed using Gramsl32
software.-
2.3 RESULTS AND DISSCUSION
2.3.1 PORPHYR.IN-ENZYA!:ffi INrERACTION
The first points to be addressed are the presence/absence ofinteraction between
TPPSI and AChE and, if applicable, the type of interaction between them. The
absorbance spectrum of monosulfonate tetraphenyl porphine (TPPS1) is shown in Figure
2.2 (Trace 1). TPPS 1 has absorbance bands in addition to those shown here at 518,552,
591, and 647 nm. For this research the focus will be in the 350 to 500 nm region where
the Soret is located. The peak shown in this figure is composed of three bands,. likely due
to different species ofTPPSI. Upon binding of AChE, a peak shift to Ionger wa~elengths
occurs as shown in Figure 2.2 (Trace 2), which is more clearly observed 1n the TPPS I +
AChE minus TPPSI difference spectrum (Figure 2.2, Trace 3). The difference spectrum,
which shows the changes in the 'fPP,SI absorbance due to enzyme binding, displays a
new absorption peak at 442 om resulting from the TPPS1-AChE complex and a trough at
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402 nm resulting from a decrease in the amount ofunbound TPPSl. This spectral shift is
independent ofpH (7 to 1]) and independent of salt eoncentration (2 mM to 100'mM).
The intensity of the peak at 442 nm resulting from the TPPSl-AChE interaction is
dependent on AChE concentration as shown in Figure 2:3. The inflection point occurs at
120 nM AChE. On the basis of the extinction coefficient (E =500 cmlrnM), the
absorbance increase at 442 rnm corresponds to 110 oM TPPSl. Therefore, there is
approximately one TPPSl per AChE. The dependence is linear.Jup to 140 nM AChE,
after which point the absorbance d6es' not increase. . .
The fluorescence spectra resulting from excitation OfTPPSI alone from 375 nm to
450 ron with emission measured from 600 om to 750 run are shown in Figure 2.4. The
peak fluorescence intensity occurs at 652 nm achieving a maximum when excited at 406
nm. In addition, a fluorescence band is observed in the region between 690 and 740 nm
with maximum intensity achieved also at 406 nm excitation. The peak emission intensity
of this region is at 712 nm. These bands are more prominent when viewed as a contour
plot (Figure 2.4).
Acetylcholinesterase alone does not exhibit fluorescence when excited from, 375
nm to 450 nm (data not shown). Excitation ofTPPSI bound to AChE,however, results in
a narrowing of the fluorescence band at 652 nm(Figure 2.5). The TPPSi-enzyme
complex also shows maximum emission and excitation wavelengths in the fluorescence
bands in the region from 690 nm to 740 nm. Figure 2.6 shows the fluorescence intensity
for TPPS1 alone (Figure. 2.6, Panel A) and in the presence of AChE (Figure 2.6, Panel B)
at 652 nm ,emission for all excitation wavelengths. The addition ofAChE does not affect
the emission peak for this band. A shift is observed in the maximum intensity excitation
11
wavelength from 407 run to 412nm (Figure 2.6). The band in the region l>etween.690nrn
and 740 nm displays shifts in both peak emis.sion andexcitatiorI wavelengthst The 'peak
intensity ofthese hands .is shifted from 712 nm to'7116 om (Figure 2.5) and the excitation
wavelength at which maximum intensity occurs shifts·from 406 om to 413 nm (Figtife
2.7, Panels AandB).. J "
It is obvious from the fluorescence and absorbance data that TPPS. and AChE
interact. Formation 'of a TPPSl-AChE complex yields a very specifi.c change in the
absorbance spectrum and several changes in the fluor,escence spectrum ofTPPSt.
The next point to be addressed is the type of interaction which exits between
TPPS1 and AChE,- The Lineweaver-Burk plofof AChE activity at different substrate
concentrations io the absence and presence of470nM TPPS t is sliowo in Figure 2.8, The
linear plots intersect oO'the Y-axis; the Km values for NrC are 87 and 141 J.IM in the
absence and presence-ofTPPSi r,espectively. The int'ersection ofthe lines on the Y-axi'S
indicate.s that TPPS t is a competitive inhibitor ofAChE, This finding is consistent with
the findings ofLee and co-workers (J3, 14), who suggest that porphyrins show either
mixed or ,competitive inhibition. OUf data supports the latter possibility. In order to
competitively inhibit an enzyme, the compound in question must bind in the active site
(64). So from this data,. we can detennine that not only do TPPS. and AChE interact but
TPPSI binds to the active site ofthe enzyme.
2.3.2 EFFECT OF SUBSTRATE ADDITION TPPS1-ENZYME COrvIPLEX
The difference spectrum TPPS 1 + AChE + AChI minus TPPSl, resulting from
addition of AChI and AChE to TPPSt , shows the combined effect of substrate and
enzyme on TPPS. (Figure 2.9, Trace 1). The difference spectrum displays a peak at 447
12
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run and trough ~ 402 nm. Tl1e TPPS1 + AChE + AChI minus TPPS1+AC~ difference
spectrum (Figure 2.9, Trace 2), which shows the change in the TPPS1 bound to AChE
due to the addition of the substrate, displays a narrowed peak at 447 nm and a trough at
402 nm. The lack of an absorbance peak at 442 run [shoulder on 447 nm peak (cf. Figu~e
2.9, Trace 2)~ its non-presence results in the "narrowing" of the 447 nm peak] in the
presence of substrate comp~ed to the absence of substrate as" seen in Figure 2.9 (Trace 3)
indicates the dissociatiqn ofTPPS l from the enzyme due to, the competitive binding ~f
the substrate (TPPS1 in solution does not sho~ a 442 nm peak; 442 nm peak is only seen
when TPPS1 is bound to AChE).
When we subtract Trace 2 ofFigure 2.~ from Trace 1 ofFigure 2.9, the result
(Figure 2.9, Trace 3) shows the same spectral characteristics as TPPS.1 + AChE minus
TPPSI (Figure 2.2, Trace 3). Since Figure 2.9 Trace 1 is the effect Gf substrate and
enzyme on TPPSI and Figure 2.9 Trace 2 is the change in the TPPSI by the enzyme, the
difference in the TPPS1 is likely attributable to the dissociation oft~e TPPSl-enzyme
complex.
That this is so is also shown by the difference spectrum OfTPPSI + AChI minus
TPPS. (indicates the effect of substrate on the TPPS1 spectrum) which shows a peak at
447 run (Table 2.1). Thus, the presence of the 447 nm peak and 442 nm trough (seen as a
shoulder on the 402 nm trough) in the TPPS1 + AChE + AChI minus TPPS1 + AChE
difference spectrum are due to the changes in the TPPSI spectrum resulting from
formation ofTPPSl-AChIcomplex as well as dissociation of the TPPSl-enzyme
complex. The narrowed 447 nm peak in the TPPS1 + AChE + AChI minus TPPSI +
AChE difference spectrum is due to the loss of the 442 nm band. As AChI displaces
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TPPS. from the active site, the 442 run band d~e to TPPS. bindipg AChE becomes
smaller.
2.3.3 EFFECT OF ACHE INHIBITORS "
:retracaine has been shown to be a competitive inhibitor of AChE (65, 66) while
procaine has. not, suggesting that tett:acaine binds to the active site while procaine binds
elsewhere, likely at the peripheral site located adjacent to, the active site (65). In the
presence oftetracaine, the TPPS I + AChE + tetracaine minus ;rpPS. difference spectrum
(Figure 2.10, Tra<:~, 1) displays a trough at 402 run and peak at 44.5 run. The loss of the
porphyrin-enzyme complex, represented by an absorbance band at 442 nm, is consistent
with tetracaine displacing the TPPS l from the enzyme active site.
By comparison, the loss of the 442 run peak is not observed when procaine (2.0
mM) is used in place oftetracaine (Figure 2.10, Trace2). The TPPSI + AChE + procaine
minus TPPSI difference spectrum shows peaks at 442 nm and 429 nm and a trough at 402
run. The interaction between TPPS. and AChE is still present (442 om band) and we
observe an interaction between TPPSI and the procaine represented by the absorbance
peak at 429 nm (Table 2.1). The binding ofan inhibitor at a site other than the active site,
therefore, does not effect the TPPS1-,enzyrne interaction strongly enough to change the
442 nm absorbance characteristic.
2.4 CONCLUSIONS
Based on the presented data. TPPSI binds to the active site of AChE in a one to
one ratio. The fonnation ofthe TPPSl-AChE complex results in a change in the spectral
characteristics OfTPPSl. The enzyme-porphyrin complex then exhibits spectral
14
'.characteristics sensitive to the presence ofchemicals which bind to the active site of
AChE.
It is interesting to note tilat it may be possible to use porphyrins to detect the
presence of specific proteins. Shifts in absorbance and fluorescence spectra tend to be
unique for different chemicals (3) including different proteins (9), Spectral shifts could
be used as a "marker" for the presence of proteinaceous bacterial exotoxins. This
category includes botulinum toxin and those found in Clostridium botulinum, Clostridium
telani, Clostridium perfringens, Escherichia coli, cholera, and plague (Yersinia pestis).
1"
15








FIGURE 2.1 Monosulfonate tetraph~nyl porphine has three hydrophobic phenyl
groups and one sulfonate group on its periphery.
- .
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FIGURE 2.2 The absolute spectrum of730 nM TPPSI (Trace 1) and the absolute
spectrum of730 nM TPPS1 + 30 nM AChE (Trace 2) show the shift,
which occurs upon formation of the TPPSI-AChE complex. The
difference spectrum TPPSI + AChE - TPPSI (Trace 3) shows interaction
peaks.
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FIGURE 2.3 The dependence on AChE concentration of the peak at 442 nm in the
difference spectrum TPPS 1 + AChE minus TPPS I.
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FIGURE 2.4 The fluores,cence ofTPPS I shows two major band groups. The strongest
has a peak ofemission at 652 nm while the other shows a peak of
emission at 712 rim.
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FIGURE 2.5 The fluorescence ofTPPS] in the presence of AChE shows two major
band groups,. The strongest emission band has a peak at 652 nm while the
other shows a peak at 716 mn.
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EMISSION INTENSITY OF TPPSl AT 652 NM IN THE
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FIGURE 2.6 The fluorescence ofTPPS. in the presence (panel A) I absence (panel B)
of AChE at 652 om, the peak emission intensity. A shift in the peak
excitation wavelength from 407 nm to 412 run is observed upon addition
of AChE.
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EMISSION INTENSITY OF TPPSI AT 712 NM AND TPPS1 IN
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FIGURE 2.7 The fluorescence OfTPPSl in the absence ofAChE (panel A) shows a
peak at 712 nm with the peak excitation wavelength at 406 nm. In the
presence of AChE (panel B), the peak emission is shifted to 716 run
with peak excitation at 413 nm.
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FIGURE 2.8 The Lineweaver-Burk plot ofAChE activity at different ATC
concentrations is shown as IN vs. lI[Sl, where V is in kmole per
minute. In the absence ofinhibitor (.) Km =87~. In the presence of
470 nM TPPS. (£) Km = 141 ~. Intersection of the curves occurs at
the Y-axis, Vmax = 0.02 kmoVmin.
23




FIGURE 2.9 Spectral changes in the TPPSI-AChE complex upon addition ofAChI.
Trace 1: the difference spectrum ofTPPS1 + AChE + AChI minus
TPPS]; Trace 2: the di~erencespectrum ofTPPS.1 (730 oM) + AChE (30
oM) + AChI (18 J.1M) minus TPPS l + AChE, Trace 3: the double
difference spectrum of(TPPSI + AChE + AChI minus TPPSl) minus
(TPPS] + AChE + AChI minus TPPS l + AChE) yields TPPS l + AChE
minus TPPSI.
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FIGURE 2.10 Trace I: The interaction ofthe TPPSI-AChE complex with tetracaine.
The difference spectrum ofTPPS l (730 nM) + AChE (30 nM) +
tetracaine (0.5 mM) minus TPPS1. Trace 2: The difference spectrum of
TPPS1 (730 nM) + AChE (30 nM) + procaine (2.0 mM) minus TPPS1 +
procame.
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DIFFERENCE SPECTRUM BAND POSITIONS
Difference Spectrum , Peak Trough
TPPS1 + AChE minus TPPS\ 442nm 402nm
TPPS\ + AChE + AChI minus TPPS\ + AChE 447nm --...:: \. -, 402 om and 442 nm
TP~S\ + AChE + AChI minus TPPS\ 447nm 402nm
TPPS\ + AChI minus TPPS. 447nm 402nm
TPPS1 + AChE + tetracaine minus TPPS. 445nm 402nm " ,.
TPPSt + tetracaine minus TPPSt 445nm 402nm 'II
TPPS\ + AChE + procaine minus TPPS\ 442 nm and 429 om 402nm ",' ,', I
TPPS\ + procaine minus TPPS1 429nm 402nm
,
TABLE 2.1 The peak and trough positions in the difference spectra resulting from the




Use of the AChE-TPPSl complex as ,a sensor to be. applied outside ofa lab" ,I
environment necessitates the formation ofa system mor,e durable and versatile than that
ofa solution. Mixing of reagents. in the field is not practical due to the time involved,
necessity ofexact measurements, and storage requirements. AChE has been proven
stable for a few weeks only if stored frozen. Enzymes are typically more stable when
they are immobilized. )n the interest ofconvenience and application in a variety of
situations, the formation of a layer of immobilized AChE has been investigated.
Severa] procedures for immobilizing enzymes are sited in the literature.
Acetylcholinesterase contains a total of76 amino group bearing Tesidues~ 26 lysine, 15
glutamine, 35 asparagine. These amino residues can be used to immobilize by binding to
a Schiffbase formed from another amino group. A brief review of a few methods
follows, as wen as, a summary ofthe progression of the immobilization technique to be
employed.
3.1 STANDARD IM:MOBILIZATIONMETHODS
3.1.1 IMM:OBILIZATION ONTO NYLON NETS
One commonly used method of immobilization is accomplished through the use
ofnylon net. This procedure is described by Mascini and co-workers (67). The nylon
netting that is used consists of 120 threads/em each having a thickness of 100 J,lM. The
nets are immersed in dimethyl sulfate at 100 C for five minutes followed by immersion in
an ice bath to stop the reaction. The nets ar,e then immersed in anhydrous methanol for
several minutes followed immediat,ely by immersion in lysine solution to coat the surface







formation of Schiffbases at the free amino groups. 'Finally the nets ar,e immersed in the
enzyme solution. This type of immobilized enzyme.has been used to make kydrogen
peroxide electrodes, oxygen ,electrodes" and Platinum electrodes (51, 54, 67).
3.1.2 IMM:OBILIZAION ONTO GLASS
A method for immobilizat~on of AChE onto glass has ·been described by Leon-
Gonzales and Townshend (51). The glass described is controned porosity glass, CPG-
240, obtained from Sigma Chemical. An aminoalkylating agent, 3-
arninopropyltriethoxysiJane (3-APTES), is reacted :with the glass. After alky,lamination,
the alkylamino glass is activated with glutaraldehyde. After being thoroughly rinsed, the
activated glass is reacted with AChE. This method has been used for. flow inJection
measurements ofenzyme inhibition (53, 57).
A slightly modified prooedure is.used for the treatment of silica gel by Simonian
and co-workers (49). They use an acetone wash following the treatment with 3-APTES.
Activation of amino groups is also achieved through the use ofglutaraldehyde. The
enzyme treated gels have been used £or flow injection experiments as well as with pH
electrodes (49, 52).
3.2 DEVELOPMENT OF DENDRIMER TECHNIQUE
3.2.1 TIlE EARLY TESTS
:Xenobind microwell plates (Xenopore, Saddle Brook, NJ) were originally used
for binding of AChE. These plates are designed to form covalent bonds with the amino
groups on the surface ofproteins.. The binding procedure recommended by Xenopore
was followed. The protein was dissolved in buffer and allowed to interact with the




sites blocked with casein. .The result was a surfaG·e with density ,quite low for the
purposes we were trying to achieve. This type ofwell also had a short lifetime based on
the decrease and cessation ofcatalytic activity ov'er a period of a few days. Enzyme
activity was measured using the method ofEUman and· ,co-workers, discussed in Part.ill.
A surface with higherellZ¥me density was required. so DNA-Bind microwell
plates (Coastar. Cambridge. MA) were investigated. DNA-Bind surfaces are again
desi,gned to interact with protein surface amino groups. Binding of AChE to the DNA-
Bind plates was attempted using the method described for the Xenobind plates. With
much the same results achieved. The DNA-Bind wens displayed low enzyme density
and lifetimes of only a few days., A modification ofthe procedure used has proven much
more successful.
For tbe new~procedure, activation ofthe weBs with glutaraldehyde is followed by
interaction with Starburst. Starburst is 'a generation 4 PAMAM dendrimer from Aldrich
Chemical Co. (Milwaukee, WI). This dendrimer forms a layer of amino group bearing
branched chains extending away from the surface of the slide. The excess Starburst is
then washed away and the well is allowed to interact with 1 M Trisma base for a short
time to block the remaining sites on the well. The Starburst treated well is then activated
by glutaraldehyde, t:'orming Schiff-bases from the amino groups. which is followed by a
rinse. The AChE is then allowed to interact with the activated dendrimer for
approximately two bours. Two methods ofblocking the excess sites on the dendrimers
have been used. The frrst method used was blocking with casein, as before. Conoerns
about casein interactions with other chemicals to be used have necessitated a new
procedure. The excess sites are currently being blOCked with TRIS, which is less likely
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to int,eract with porphyrins in a manner similar to AChE.. Blocking reduces non-specific
interactions of the porphyrin with the Starburstas well as,stabilizing the 'enzyme. The
Starburst treated plates show much higher catalytic activity, indicating higher 'enzyme
density, than the previous types and the lifetime has been extended to thirty-days when
refrigerated, indicating greater stability. The catalytic lifetime of the wells showed no pH
dependence when stored from pH 5 to 9.
3.2.2 FINAL MODIFICATIONS
The wells themselves presented some problems. The weBs are ofclear plastic
with dimensions that are inconvenient, 7 mm diameter cylinder with height 10 mm,
which restricts their measurement in a spectrophotometer. The new binding method
offers some concern as to the proximity of the sides ofthe wells. There is a possibility of
binding the enzyme to the sides rather-than the bottom making measurements more
difficult. The small size ofthe surface was also of some concern in that we would be
trying to measure spectral changes with a very small number ofenzymes present. The
available number ofenzymes strongly effects the detection limit. The less enzymes
which are effiected, the smaller the absorbance ~hange, so with more enzymes present on
the surface the lower limit ofdetection can be reduced. The small number ofparticles
would also limit the reusability of the surface. Reusability in this case refers to the fact
that not all enzymes are effected upon exposure to an inhibitor. These intact enzyme-
porphyrin complexes can be effected by subsequent exposure to inhibitors. All of these
difficulties could be alleviated through the use of a flat surface.
The immobilization technique previously described is applied to ProbeOn Plus




ProbeOn Plus slides have a prepared surface so that ,activation with glutaraldehyde fonns
Schiff bases from the present amino groups wMch can subsequently bind other amino
groups. The catalyti,c lifetime is approximately thirty days for casein-blocked slides and
somewhat less for TRIS-blocked slides. Catalytic activity cannot be measured using the
Ellman procedure after exposure to TPPSt. Preliminary studies, however, show that' )
TPPSt extends the lifetime ofthe immobilized AChE ifit is applied before 'storage. The
slides show high enzyme density across the larger surface area. The use ofglass instead
of plastic allows for application with different types ofspectrometers and resistance to
damage by different environments.
The den.sity ofthe bound AChE can be increased by using the glutaraldehyde-
starburst sequence twice. Catalytic activity studies indicate that they are less stable than
slides tr,eated only onc,e.. It may be possible to extend the usable lifetime ofthese slides
by treating with TPPSI prior to storage. Activity is maintained at higher levels for longer
periods of time when the slides are stored refrigerated in buffer. Further testing of these






The ultimate goal oftins project is to develop a real time detector for ., ,
acetylcholinesterase inhibitors, organophosphates, nerve gases, drugs, and pesticides, in
air and water. Preliminary work has been done using the immobilized AChE with TPPS 1
and inhibitors in solution. To understand how the immobiJized enzyme performs as
compared to the enzyme in solution, different methods ofexposure to TPPS1 have been
emp~oyed as wen as different methods of exposure to inhibitors and to substrate.
4.1 PRELIMINARY RESULTS
4.1.1 :MEASUREMENT TECHNIQUE
Preliminary data has been coUeeted in the form ofabsorbance spectra generated
through the use of the experimental setup shown in F;igure 4.1. Absorbance spectra were
coUected using a dual wavelength spectrophotometer (SDB - 3 Johnson Research
Foundation, University ofPennsylvania, Philadelphia, PA). The output of the
spectrophotometer was focused o~to the round end of a I/s" optical fiber bundle that
terminates in a linear array (circular to linear bundle; Dolan-Jenner). The microscope
slide (n = 1.5151) is butted against the linear array such that the light enters the plane of
the glass. On the opposite side ofthe slide (1" distance), the slide butts against another
linear to circular bundle to gather the light transmitted through and evanescently along
the slide surface (68-7J). The circular end of the bundle is then placed for maximal
illumination ofthe R928 photomultiplier photocathode ~igure 4.1).
4.1.2 :METHODS OF EXPOSURE TO TPPS1
32
In order to bind TPPS1 to the active site ofimmobilized AChE; 200~ ofa 74
.~ TPPSI solution is then placed on the slide and ~mowed to interact for 15 minutes.
The excess is then washed away with 50 roM pH 7 sodium phosphate buffet.' It has been
detennined that this method is preferable to allowing the TPPSI solution to dry on the
slide. As the solution dries, the TPPS1 dries in a high concentration that causes stacking
OfTPPSl and distorts the interaction with other chemicals (3). Exposure to AChE
inhibitors and substrates is achieved in a similar manner, with the concentrations in··
solution as desired. "
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slides. Addition oftetracaine, a competitive inhibitor 'of AChE, should, as observed in
solution, displace TPPSI from the active site, and result in a~ absorbance decrease at 446
run (the wavelength of the TPPS1-immobilized AChE complex). f..s seen ill Figure 4.4, a
decrease-in absorbance at 446 run is seen in the presence of3ppb (10 QM) tetracaine in
both the absolute (Trace 2) and the difference spectrum (Trace 3). .
The decrease in intensity ofthe 446 nm peak is linearly d~pe~dent on tetracaine
concentration from 300 ppt (10M) to 100 ppb (333 oM) (Figure 4.4, P~el A). , When
the change in absorbance is plotted versus the log of tetracaine concentration, two slopes
are observed as seen in Figur,e 4.5, Panel B. The limits.ofdetection commonly sought
for nerve agents.are approximately 2 - 5 micrograms per liter (2-5 ppb). On the basis of
Figure 4.5, it appears that 300 ppt rnayapproach the detection limit for this method based
on sensitivity of the spectrophotometer.
4.2 FUTURE WORK
As earlier stated, the intent of this project is the ability to detect
acetylcholinesterase inhibitors at low J,evels in several types of samples. The immediate
goals will be (1) further development of immobilization techniques in the hope that a
higher AChE density can be achieved on the slides and (2) a better understanding ofthe
interactions which take place between the AChE, TPPS), inhibitors, and substrates in this
new type ofenvironment. Higher AChE density, will allow for a larger signal to noise
ratio. The greater this ratio the more reliable the readings become and the lower the
concentration.ofinhibitor required for detection. The binding affinity ofAChE for
TPPS1 must be Jess than that of AChE for the inhibitor to be detected in order for this
34
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type ofsensor to function. Knowledge ofthe association constants-for AChE, its
inhibitors, and TPPS 1 is important for prediction of sensor performance.
While the optical detection spectrophotometer utilized in this study was a bench
mounted unit, the magnitude of the absorbance change is obtainable by smaller less-
expensive units, including handheld CCD/diode array based spectrometers. That the
absorbance cbang,es are observed at specific wavelengths also allows for the use of small
solid-state photodiodes fitted with ba~dpass filters at the appropriate wavelengths. A
portable unit, utilizing these types ofcomponents is planned to facilitate application in
the field. Cost for one slide, excluding labor, is less than five dollars. It is likely that a
I










FIGURE 4.1 The experimental setup for measurement of immobilized enzymes on
ProheOn slides uses a fiber optic light source and measures absorbance
through the use ofthe evanescent wave.
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FIGURE 4.2 Trace 1 shows TPPSI on a ProbeOn slide. The porphyrin is not
covalently bound, it is held only by weak interactions. Trace 2 shows
TPPS1 on a ProbeOn slide which holds immobilized AChE. Both
interactions with the AChE and with the slide result in this case.
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FIGURE 4.3 Exposure ofthe immobilized TFPS.-AChE complex (Trace 1) to AChI
results in expulsion OfTPPSl from the active site of AChE (Trace 2).
This is seen in the difference spectrum, TPPS. + AChE + AChI minus
TPPSI + AChE as a loss at 446 nm.
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FIGURE 4.4 Exposure ofthe immobilized AChE-TPPSl complex (Trace 1) to
tetracaine (3 ppb) causes expulsion ofTPPS1 from the act'ive site of
AChE (Trace 2). This is seen as a loss in the peak at 446 nm in the
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FIGURE 4.5 The dependence on tetracaine concentration of the 446 run absorbance
change. Panel A. Change in absorbance versus tetracaine concentration.
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